Assessment of inflammation in large arteries with 18F-FDG-PET in elderly

Computerized Medical Imaging and Graphics

Volumn 37, Issue 7-8, 2013, Pages 459-465

  Orellana, Marlene Rossibel Montesino ^a   Bentourkia, M'hamed ^a   Sarrhini, Otman ^a   Fulop, Tamas ^a   Paquet, Nancy ^a   Lavallée, Éric ^a   Turcotte, Éric ^a   Khalil, Abdelouahed ^a  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

Author keywords

18F Fluorodeoxyglucose; Aging; Atherosclerosis; Inflammation; Large arteries; Positron emission tomography

Indexed keywords

18-F-FLUORODEOXYGLUCOSE; ATHEROSCLEROSIS; FEMORAL ARTERY; INFLAMMATION; LARGE ARTERIES; REPEATED MEASUREMENTS; STANDARD UPTAKE VALUES; SYSTEMIC INFLAMMATION;

AGING OF MATERIALS; BIOMINERALIZATION; BONE; DISEASES; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY;

COMPUTERIZED TOMOGRAPHY;

FLUORODEOXYGLUCOSE F 18; ROSUVASTATIN;

AGED; AORTA; ARTICLE; ATHEROSCLEROSIS; CALCIFICATION; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; FEMALE; FEMORAL ARTERY; HUMAN; ILIAC ARTERY; INFLAMMATION; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TREATMENT DURATION;

18F-FLUORODEOXYGLUCOSE; AGING; ATHEROSCLEROSIS; INFLAMMATION; LARGE ARTERIES; POSITRON EMISSION TOMOGRAPHY;

AGED; AORTA; ARTERITIS; FEMALE; FEMORAL ARTERY; FLUORODEOXYGLUCOSE F18; HUMANS; ILIAC ARTERY; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; OBSERVER VARIATION; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; VASCULAR CALCIFICATION;

EID: 84888062682     PISSN: 08956111     EISSN: 18790771     Source Type: Journal    
DOI: 10.1016/j.compmedimag.2013.09.006     Document Type: Article

References (42)

1. Mendis S., et al. World Health Organization definition of myocardial infarction: 2008-09 revision. Int J Epidemiol 2011, 40(1):139-146.
2. Libby P. Inflammation and cardiovascular disease mechanisms. Am J Clin Nutr 2006, 83(2):456S-460S.
3. Vanhoutte P.M., et al. Endothelial dysfunction and vascular disease. Acta Physiol 2009, 196(2):193-222.
4. Nighoghossian N.L., Derex P., Douek The vulnerable carotid artery plaque: current imaging methods and new perspectives. Stroke 2005, 36(12):2764-2772.
5. Packard R.R., Libby P. Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction. Clin Chem 2008, 54(1):24-38.
6. Farouque H.M., Meredith I.T. The assessment of endothelial function in humans. Coron Artery Dis 2001, 12(6):445-454.
7. Revkin J.H., et al. Biomarkers in the prevention and treatment of atherosclerosis: need, validation, and future. Pharmacol Rev 2007, 59(1):40-53.
8. Naghavi M., et al. New developments in the detection of vulnerable plaque. Curr Atheroscler Rep 2001, 3(2):125-135.
9. Fayad Z.A., Fuster V. Clinical imaging of the high-risk or vulnerable atherosclerotic plaque. Circ Res 2001, 89(4):305-316.
10. Voros S., et al. Coronary atherosclerosis imaging by coronary CT angiography: current status, correlation with intravascular interrogation and meta-analysis. JACC Cardiovasc Imaging 2011, 4(5):537-548.
11. Achenbach S., Raggi P. Imaging of coronary atherosclerosis by computed tomography. Eur Heart J 2010, 31(12):1442-1448.
12. de Feyter P.J., et al. Quantitative coronary angiography to measure progression and regression of coronary atherosclerosis. Value, limitations, and implications for clinical trials. Circulation 1991, 84(1):412-423.
13. Topol E.J., Nissen S.E. Our preoccupation with coronary luminology. The dissociation between clinical and angiographic findings in ischemic heart disease. Circulation 1995, 92(8):2333-2342.
14. Tardif J.C. Atherosclerosis imaging. Can J Cardiol 2005, 21(12):1035-1039.
15. Guedes A., Tardif J.C. Intravascular ultrasound assessment of atherosclerosis. Curr Atheroscler Rep 2004, 6(3):219-224.
16. Motoyama S., et al. Atherosclerotic plaque characterization by 0.5-mm-slice multislice computed tomographic imaging. Circ J 2007, 71(3):363-366.
17. Bose D., von Birgelen C., Erbel R. Intravascular ultrasound for the evaluation of therapies targeting coronary atherosclerosis. J Am Coll Cardiol 2007, 49(9):925-932.
18. Agatston A.S., et al. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990, 15(4):827-832.
19. Vallabhajosula S., Fuster V. Atherosclerosis: imaging techniques and the evolving role of nuclear medicine. J Nucl Med 1997, 38(11):1788-1796.
20. Sheikine Y., Akram K. FDG-PET imaging of atherosclerosis: do we know what we see?. Atherosclerosis 2010, 211(2):371-380.
21. Andrews J., et al. Non-invasive imaging in the diagnosis and management of Takayasu's arteritis. Ann Rheum Dis 2004, 63(8):995-1000.
22. Bural G.G., et al. FDG-PET is an effective imaging modality to detect and quantify age-related atherosclerosis in large arteries. Eur J Nucl Med Mol Imaging 2008, 35(3):562-569.
23. Dunphy M.P., et al. Association of vascular 18F-FDG uptake with vascular calcification. J Nucl Med 2005, 46(8):1278-1284.
24. Tatsumi M., et al. Fluorodeoxyglucose uptake in the aortic wall at PET/CT: possible finding for active atherosclerosis. Radiology 2003, 229(3):831-837.
25. Joly L., et al. Aortic inflammation, as assessed by hybrid FDG-PET/CT imaging, is associated with enhanced aortic stiffness in addition to concurrent calcification. Eur J Nucl Med Mol Imaging 2009, 36(6):979-985.
26. Tahara N., et al. The prevalence of inflammation in carotid atherosclerosis: analysis with fluorodeoxyglucose-positron emission tomography. Eur Heart J 2007, 28(18):2243-2248.
27. Tawakol A., et al. In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. J Am Coll Cardiol 2006, 48(9):1818-1824.
28. Rudd J.H., et al. Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: implications for atherosclerosis therapy trials. J Am Coll Cardiol 2007, 50(9):892-896.
29. Arauz A., et al. Carotid plaque inflammation detected by 18F-fluorodeoxyglucose-positron emission tomography. Pilot study. Clin Neurol Neurosurg 2007, 109(5):409-412.
30. Davies J.R., et al. Identification of culprit lesions after transient ischemic attack by combined 18F fluorodeoxyglucose positron-emission tomography and high-resolution magnetic resonance imaging. Stroke 2005, 36(12):2642-2647.
31. Wykrzykowska J., et al. Imaging of inflamed and vulnerable plaque in coronary arteries with 18F-FDG PET/CT in patients with suppression of myocardial uptake using a low-carbohydrate, high-fat preparation, Journal of nuclear medicine: official publication. Soc Nucl Med 2009, 50(4):563-568.
32. Meirelles G.S.M., Strauss H.W.G. 18F-FDG uptake and calcifications in the thoracic aorta on positron emission tomography/computed tomography examinations: frequency and stability on serial scans. J Thorac Imaging 2011, 26(1):54-62.
33. Tahara N., et al. Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography. J Am Coll Cardiol 2006, 48(9):1825-1831.
34. Menezes L.J., et al. Vascular inflammation imaging with 18F-FDG PET/CT: when to image?. J Nucl Med 2009, 50(6):854-857.
35. Verbraecken J., et al. Body surface area in normal-weight, overweight, and obese adults. A comparison study. Metabolism 2006, 55(4):515-524.
36. Jones P.H., et al. Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial). Am J Cardiol 2003, 92(2):152-160.
37. Nicholls S.J., et al. Effect of two intensive statin regimens on progression of coronary disease. New Eng J Med 2011, 365(22):2078-2087.
38. Liao J.K., Laufs U. Pleiotropic effects of statins. Annu Rev Pharmacool Toxicol 2005, 45:89-118.
39. Ridker P.M., et al. Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. New Eng J Med 2001, 344(26):1959-1965.
40. Chen W., et al. Emerging role of FDG-PET/CT in assessing atherosclerosis in large arteries. Eur J Nucl Med Mol Imaging 2009, 36(1):144-151.
41. Libby P., Ridker P.M., Hansson G.K. Inflammation in atherosclerosis. From pathophysiology to practice. J Am Coll Cardiol 2009, 54(23):2129-2138.
42. Bentourkia M. Kinetic modeling of PET data without blood sampling. IEEE Trans Nucl Scie 2005, 52(3):697-702.